Home›Stocks›ARQT

ARQT — structural market context

Arcutis Biotherapeutics, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

ARQT short interest & days to cover

SHARES SHORT
12.7M
% OF FLOAT
—
DAYS TO COVER
10.7
CHANGE VS PRIOR
-6.5%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (38d ago)

ARQT fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-08-11 · 27d16$25.92
2026-08-04 · 34d13K$25.94
2026-07-29 · 40d6$28.42

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

ARQT insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 6 sales

InsiderTypeSharesValueFiled
Curran Terrie · directorSell (S)27K$677K2026-08-28
Curran Terrie · directorSell (S)1K$28K2026-08-24
Burnett Patrick · officer: See RemarksSell (S)2K$46K2026-08-21
Welgus Howard G. · directorSell (S)5K$124K2026-08-19
Burnett Patrick · officer: See RemarksSell (S)8K$220K2026-08-13

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying ARQT?
In the last 12 months of SEC Form 4 filings, ARQT recorded 0 open-market insider purchases and 6 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell ARQT?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.